0794 (0794) Fair Value & Analysis

Basic Materials · Market cap HK$82.8M

0 0794 0794 · HK

PriceHK$0.2500

Fair ValueHK$0.6900

Upside+176.0%

Quality61/100

Evidence: Medium Range HK$0.5900 – HK$0.6900

Fair value as of: Jul 2, 2026

From 13 valuation models · updated today

Share price −12.3% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1570 – HK$0.2850 · fair‑value band HK$0.5900 – HK$0.6900 · the HK$0.2500 price screens below the HK$0.6900 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0794 (0794) currently trades at HK$0.2500, while our model-based Fair Value estimate is HK$0.6900 — implying the stock looks roughly 176.0% undervalued today. We read business quality at 61/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 0794 generated revenue of HK$734M at a net margin of 0.6%. Revenue declined 6.8% year over year. It earns a return on equity of 0.9%. Net debt stands at HK$194M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$734M

Revenue growth (YoY) -6.8%

Net margin 0.6%

Return on equity 0.9%

Free cash flow −HK$4.5M FY2025

P/E ratio 25.0

More key figures

Operating margin 2.5%

EPS (TTM) HK$0.0100

EPS growth (YoY) +31.1%

Net debt HK$194M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0794 reported revenue of HK$760M in FY2025 versus HK$1.2B in FY2021, a compound −10.8%/yr. Reported net income was HK$2.3M in FY2025, compounding −46.4%/yr from FY2021.

Revenue −10.8%/yr

FY21 HK$1.2B

FY22 HK$1.2B

FY23 HK$787M

FY24 HK$765M

FY25 HK$760M

Net income −46.4%/yr

FY21 HK$27.3M

FY22 −HK$39.0M

FY23 −HK$67.2M

FY24 −HK$15.8M

FY25 HK$2.3M

Is 0794 fairly valued? → Check now

Similar stocks

6 more Paper & Paper Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Klabin S.A KLBN11	R$17.05	R$12.20	-28%
UPM-Kymmene Oyj UPMKF	$29.33	$17.60	-40%
Suzano S.A SUZB3	R$41.74	R$19.19	-54%
Svenska Cellulosa Aktiebolaget SCA (publ) SCAB	kr 100.20	kr 49.40	-51%
Shandong Sunpaper Co 002078	¥12.75	¥17.29	+36%
Holmen AB HLMMF	$35.72	$28.52	-20%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0794 (0794) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.6900 versus a price of HK$0.2500 — about +176% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0794?

Our model-based fair value for 0794 is HK$0.6900 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2500.

What is the quality score of 0794?

0794 has a Quality Score of 61/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0794 (0794)?

0794 reported trailing-twelve-month revenue of about HK$734M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0794?

The net profit margin of 0794 is about 0.6%, meaning it keeps roughly 0.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.